One example of this is connected inhalers from Propeller Health. By creating a connected inhaler, patients with asthma and chronic obstructive pulmonary disease have much better objective data regarding their usage. Prior to this, at best, patients would keep usage diaries to share with providers, but more commonly, it was just a vague estimation of use. Now, definitive data on frequency of use, time of day, and weather can be acquired and correlated. One may also be able to determine geographic areas that seem to trigger an increased use of medication. Not only do these data allow the user to be more actively involved in the management of the disease, but they also create a novel way in which the patient can engage with a health care provider. As emergency physicians, we can expect to be shown the app or printouts that summarize the data captured by a connected inhaler.
Explore This IssueACEP Now: Vol 36 – No 01 – January 2017
AliveCor’s Kardia (~$125) has been on the market now for a few years and provides a single-lead ECG when the user puts fingers from each hand on the back of an integrated mobile phone case. The Food and Drug Administration (FDA) approved machine learning algorithms that can help differentiate atrial fibrillation from normal sinus rhythm. Large data sets are available to be shared with emergency physicians upon arrival to the emergency department. Even more compelling is the Kardia wristband, which is pending FDA 510(k) clearance. This will take the technology one step further by providing passive, continuous cardiac rhythm monitoring. AliveCor claims that the device improves outcomes, reduces cost, increases workflow productivity, and deepens clinician-patient relationships. On Sept. 8, 2016, AliveCor announced a partnership with Omron that integrates blood pressure readings from Omron devices (~$65) with the Kardia app, creating a more robust data set.
Products like MedMinder have reported functionality that will take medication reconciliation to the next level, certainly something we may come across in the emergency department. There are alerts, texting functionality, and online reports that emergency physicians may be assessing.
Medication compliance is a huge issue in medicine. A number of entrepreneurs are attempting to tackle this by better controlling distribution of medications. There are a number of companies that have developed pill-dispensing systems, some of them attached to the pill bottle itself. Appropriate medication dosing can be accurately adhered to, ensuring that people take their medication and that people don’t overdose. Products like MedMinder have reported functionality that will take medication reconciliation to the next level, certainly something we may come across in the emergency department. There are alerts, texting functionality, and online reports that emergency physicians may be assessing. A step further are digestible digital medicines with sensors embedded in pills from the company Proteus Digital Health. It has developed an ingestible sensor the size of a grain of sand that, when ingested, sends a recordable signal to a patch that the patient wears on the torso. These data are transmitted to the patient’s mobile device and up to the cloud, where they sit in a portal that allows providers to access and review a patient’s medication administration history. This takes medication compliance from subjective data (self-reporting) to objective data (sensor reporting), thereby optimizing adherence and patient outcomes.